I agree that this site is using cookies. You can find further informations here.
X
Fresa, Alberto
37  results:
Articles (Online) X
Search for persons X
?
1

Venetoclax infectious risk score to identify patients with ..:

Autore, Francesco ; Visentin, Andrea ; Deodato, Marina...
American Journal of Hematology.  99 (2024)  5 - p. 982-984 , 2024
Link: https://doi.org/10.1002/..
 
?
2

CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA: CAR-T and CLL:

Testa, Ugo ; Pelosi, Elvira ; Castelli, Germana..
Mediterranean Journal of Hematology and Infectious Diseases.  16 (2024)  1 - p. e2024045 , 2024
Link: https://doi.org/10.4084/..
 
?
3

Unselected donor‐derived hematopoietic stem cells boost for..:

Galli, Eugenio ; Limongiello, Maria Assunta ; Metafuni, Elisabetta...
American Journal of Hematology.  99 (2024)  4 - p. 751-754 , 2024
Link: https://doi.org/10.1002/..
 
?
4

What Does Atypical Chronic Lymphocytic Leukemia Really Mean..:

D'Arena, Giovanni ; Vitale, Candida ; Pietrantuono, Giuseppe...
Cancers.  16 (2024)  2 - p. 469 , 2024
Link: https://doi.org/10.3390/..
 
?
5

Acute graft versus host disease 1976–2020: reduced incidenc..:

Di Francesco, Alessandra ; Raiola, Anna Maria ; Dominietto, Alida...
Frontiers in Medicine.  10 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
6

Treatment Sequencing in Chronic Lymphocytic Leukemia in 202..:

Fresa, Alberto ; Innocenti, Idanna ; Tomasso, Annamaria...
Cancers.  16 (2024)  11 - p. 2011 , 2024
Link: https://doi.org/10.3390/..
 
?
7

Measurable residual disease in chronic lymphocytic leukemia:

Benintende, Giulia ; Pozzo, Federico ; Innocenti, Idanna...
Frontiers in Oncology.  13 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
8

PB1942: PARTIAL RESPONSE WITH LYMPHOCYTOSIS (PR-L) IS NOT A..:

Innocenti, Idanna ; Mosca, Antonio ; Tomasso, Annamaria...
HemaSphere.  7 (2023)  S3 - p. e83737e4 , 2023
Link: https://doi.org/10.1097/..
 
?
9

Treatment Sequencing and Outcome of Chronic Lymphocytic Leu..:

Innocenti, Idanna ; Fresa, Alberto ; Tomasso, Annamaria...
Cancers.  15 (2023)  23 - p. 5592 , 2023
Link: https://doi.org/10.3390/..
 
?
10

Signal management and risk minimization strategy: a case st..:

Valdiserra, Giulia ; Mores, Nadia ; Rocchi, Rosalba Elisabetta...
Frontiers in Drug Safety and Regulation.  3 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
11

Lymphadenopathy as a predictor of progression during veneto..:

Autore, Francesco ; Innocenti, Idanna ; Reda, Gianluigi...
Hematological Oncology.  41 (2023)  5 - p. 877-883 , 2023
Link: https://doi.org/10.1002/..
 
?
12

PB1933: TREATMENT SEQUENCING AND OUTCOME OF CHRONIC LYMPHOC..:

Fresa, Alberto ; Autore, Francesco ; Innocenti, Idanna...
HemaSphere.  7 (2023)  S3 - p. e52643f5 , 2023
Link: https://doi.org/10.1097/..
 
?
13

S149: OTHER MALIGNANCIES IN THE HISTORY OF CLL: THE FINAL A..:

Chatzikonstantinou, Thomas ; Scarfò, Lydia ; Karakatsoulis, Georgios...
HemaSphere.  7 (2023)  S3 - p. e24596f8 , 2023
Link: https://doi.org/10.1097/..
 
?
14

P1305: NEPA VERSUS ONDANSETRON FOR THE PREVENTION OF CINV I..:

Innocenti, Idanna ; Tomasso, Annamaria ; Mosca, Antonio...
HemaSphere.  7 (2023)  S3 - p. e3758967 , 2023
Link: https://doi.org/10.1097/..
 
?
15

Role of microRNAs in Chronic Lymphocytic Leukemia:

Autore, Francesco ; Ramassone, Alice ; Stirparo, Luca...
International Journal of Molecular Sciences.  24 (2023)  15 - p. 12471 , 2023
Link: https://doi.org/10.3390/..
 
1-15